Group One Trading’s ProKidney PROK Stock Holding History

Group One Trading’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4K	Sell	7,500 -54,400	-88%	-$115K	﹤0.01%	6198
2025 Q4	$139K	Sell	61,900 -8,600	-12%	-$22.6K	﹤0.01%	4705
2025 Q3	$171K	Buy	+70,500	New	+$188K	﹤0.01%	4840

Other funds holding PROK

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's PROK Position: Q1 2026 in Review

Group One Trading sold out of ProKidney (PROK) in Q1 2026, closing a stake of 28,021 shares — an estimated $59.4K sold.

Group One Trading first reported a position in PROK in Q2 2024 and held it in 4 quarters. The position peaked at $62.8K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

Group One Trading reported no remaining ProKidney position as of Q1 2026 after selling out during the quarter.
Group One Trading sold 28,021 ProKidney shares in Q1 2026, an estimated $59.4K.
Group One Trading first reported a position in ProKidney in Q2 2024 and held it in 4 quarters.
Group One Trading's ProKidney position peaked at $62.8K in Q4 2025.
71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.